VolitionRx Limited Long-Term Debt
VolitionRx Limited (VNRX) had Long-Term Debt of $5.98 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-13
- 2026-06-30: Long-term Debt, Excluding Current Maturities $5.98M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $6.35M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $5.82M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $5.57M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $5.98M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $6.35M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $5.82M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $5.57M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.77M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $5.53M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $3.95M 10-K · filed 2026-03-31 |
| 2024-09-30 | $3.84M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.87M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $3.37M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $3.62M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.09M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.45M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.55M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.78M 10-K · filed 2024-03-25 |
| 2022-09-30 | $2.28M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.74M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $2.03M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $2.27M 10-K · filed 2023-03-15 |
| 2021-09-30 | $2.03M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.22M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $2.39M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.61M 10-K · filed 2022-03-30 |
| 2020-09-30 | $1.83M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $1.91M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $2.06M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.20M 10-K · filed 2021-03-22 |
| 2019-09-30 | $1.73M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.96M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $1.80M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.98M 10-K · filed 2020-02-20 |
| 2018-09-30 | $1.87M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.98M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $1.30M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.31M 10-K · filed 2019-03-13 |
| 2017-09-30 | $1.05M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.06M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $691.89K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $432.03K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |